In July 2018, a U.S. Senate report revealed the massive overprescribing of opioid painkillers to Missourians that has been going on unabated for years.
In Part I of this series, we looked at the emergence of an opioid epidemic in the U.S. that was fueled by the overprescribing of painkillers by doctors in every corner of the country. Now it looks like this problem may soon take on global proportions.
In New York City, Queens pharmaceutical distributor and its parent company. Kinray, LLC will be paying a $10 million penalty and parent company Cardinal will be yielding an additional $34 million to the DEA. Their offenses? Failing to report drugstores making excessive orders of addictive substances.
Prescription drugs can be wonderfully helpful in limited medical situations, but their help comes at a steep price.